Ally Bridge Group’s ESSA Pharma EPIX Stock Holding History

Ally Bridge Group’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-236,583	Closed	-$703K	–	18
2023 Q1	$703K	Sell	236,583 -574,972	-71%	-$1.69M	0.92%	16
2022 Q4	$2.05M	Buy	+811,555	New	+$2.33M	1.99%	22
2021 Q3	–	Sell	-363,185	Closed	-$10.4M	–	34
2021 Q2	$10.4M	Hold	363,185	–	–	2.58%	20
2021 Q1	$10.6M	Buy	363,185 +285,000	+365%	+$6.62M	2.02%	15
2020 Q4	$933K	Buy	+78,185	New	+$550K	0.16%	29

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Ally Bridge Group's EPIX Position: Q2 2023 in Review

Ally Bridge Group sold out of ESSA Pharma (EPIX) in Q2 2023, closing a stake of 236,583 shares — an estimated $703K sold.

Ally Bridge Group first reported a position in EPIX in Q4 2020 and held it in 5 quarters. The position peaked at $10.6M in Q1 2021. 39 funds tracked by Wall St. Rank hold EPIX as of Q2 2023.

Ally Bridge Group reported no remaining ESSA Pharma position as of Q2 2023 after selling out during the quarter.
Ally Bridge Group sold 236,583 ESSA Pharma shares in Q2 2023, an estimated $703K.
Ally Bridge Group first reported a position in ESSA Pharma in Q4 2020 and held it in 5 quarters.
Ally Bridge Group's ESSA Pharma position peaked at $10.6M in Q1 2021.
39 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2023.

Based on Ally Bridge Group's 13F filing for Q2 2023, filed 14 Aug 2023.